US$ 24.04
mothertobaby tirzepatide breastfeeding fact sheet Staying in Scope: Understanding COVID-19 and GLP-1 Medication Exposures in Pregnancy mothertobaby semaglutide pregnancy fact sheet
Description
It is important for patients to monitor their bowel habits closely, especially when they begin tirzepatide, as early detection can lead to more effective management strategies
Tirzepatide works by allowing GIP and GLP-1 to stimulate the pancreas to increase the amount of insulin released in response to meals, encouraging healthy blood glucose regulation

Dosage & Usage Administered once weekly by subcutaneous injection Use strictly as prescribed by healthcare professional Follow recommended diet and exercise plan Possible Side Effects Nausea, vomiting, diarrhea, constipation, decreased appetite, stomach discomfort

If your dose requires more than 50 units, use a 1mL (100-unit) syringe

Use a U-100 insulin syringe if your dosing instructions are in units, which is the standard
